Open AccessTerbutaline-induced neonatal ventricular tachycardia: A case report and review of literature
Author(s) -
Phillip Edwin Nehls,
Ramesh M Bhat,
Lynn Batten
Publication year - 2020
Publication title -
annals of pediatric cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 19
eISSN - 0974-2069
pISSN - 0974-5149
DOI - 10.4103/apc.apc_102_19
Subject(s) - medicine , terbutaline , ventricular tachycardia , cardioversion , tachycardia , neonatal intensive care unit , gestation , cardiology , anesthesia , pediatrics , pregnancy , atrial fibrillation , asthma , biology , genetics
Neonatal ventricular tachycardia (VT) is an extremely rare condition. We present a 35-week-old gestation neonate who developed tachycardia following maternal exposure to terbutaline. Upon transfer to our neonatal intensive care unit, an electrocardiogram (ECG) was obtained which was consistent with VT. The arrhythmia did not respond to vagal maneuvers or adenosine but resolved following cardioversion demonstrated on postcoversion ECG. At outpatient follow-up, the infant had no further episodes of arrhythmia. To the best of our knowledge, this represents the first case describing terbutaline-induced fetal or neonatal VT.